Current approaches to antenatal vitamin D supplementation do not account for inter-individual differences in 25-hydroxyvitamin D [25(OH)D] response.
We assessed which maternal and environmental characteristics were associated with 25-hydroxyvitamin D [25(OH)D] following supplementation with cholecalciferol.
Within-randomisation-group analysis of participants in the MAVIDOS trial of vitamin D supplementation in pregnancy.Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- Endocrine Society Publisher's website
- Journal of Clinical Endocrinology and Metabolism Journal website
- Publication date:
- Acceptance date:
0021-972X and 1945-7197
- Pubs id:
- Local pid:
- Copyright holder:
- Endocrine Society
- Copyright date:
- Copyright © 2016 by the Endocrine Society. This article has been published under the terms of the Creative Commons Attribution License (CC-BY;https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Copyright for this article is retained by the author(s).
Determinants of the maternal 25-hydroxyvitamin D response to vitamin D supplementation during pregnancy.
If you are the owner of this record, you can report an update to it here: Report update to this record